Estrogen-dependent TRX2 activation reverts oxidative stress and metabolic dysfunction associated to steatotic disease
Andrea Morandi(University of Florence), Andrea Perra(University of Cagliari)
Cited by 0
Related Papers
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
|International Journal of Molecular Sciences|2021|77
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts
|Oncotarget|2016|33
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
|Cell Death and Disease|2025|20
FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1